Loading…

Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents

•Baseline thrombocytopenia in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents is not uncommon.•Thrombocytopenic patients have increased mortality risk after PCI.•Moderate-to-severe thrombocytopenia increases the risk of major bleeding after PCI. Platelets are cr...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2020-11, Vol.134, p.55-61
Main Authors: Park, Sangwoo, Ahn, Jung-Min, Kim, Tae Oh, Park, Hanbit, Cho, Sang-Cheol, Kang, Do-Yoon, Lee, Pil Hyung, Park, Duk-Woo, Park, Seung-Jung
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Baseline thrombocytopenia in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents is not uncommon.•Thrombocytopenic patients have increased mortality risk after PCI.•Moderate-to-severe thrombocytopenia increases the risk of major bleeding after PCI. Platelets are crucial in the pathophysiology of coronary artery disease and are a major target of antithrombotic agents in patients receiving percutaneous coronary intervention (PCI). We sought to evaluate the incidence and prognostic impact of thrombocytopenia on clinical outcomes in patients undergoing PCI with drug-eluting stents (DES). We evaluated consecutive patients who received PCI with DES in the IRIS-DES registry between April 2008 and December 2017. Patients were divided into 2 groups based on the presence of thrombocytopenia (platelet count
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2020.07.059